1. 2022-RA-1263-ESGO Phase II randomized BGOG-CX3 trial comparing atezolizumab in combination with doxorubicin versus doxorubicin alone in second-line or later recurrent cervical cancer. (20th October 2022) Authors: Loverix, Liselore; Salihi, Rawand; van Rompuy, Anne-Sophie; Vanderstichele, Adriaan; van Nieuwenhuysen, Els; Baert, Thaïs; Debruyne, Philip; Cornez, Nathalie; Henry, Stéphanie; Neven, Patrick; Han, Sileny; Berteloot, Patrick; Olbrecht, Siel; Laga, Tina; Busschaert, Pieter; van Gorp, Toon; Vergote... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2022-RA-1473-ESGO Randomized phase II CLIO study on olaparib monotherapy versus chemotherapy in recurrent ovarian cancer – results of the Leuven HRD test. (20th October 2022) Authors: Loverix, Liselore; Vergote, Ignace; Vanderstichele, Adriaan; Busschaert, Pieter; Boeckx, Bram; Venken, Tom; van Nieuwenhuysen, Els; Baert, Thaïs; Han, Sileny; Neven, Patrick; Berteloot, Patrick; Olbrecht, Siel; Laga, Tina; Lambrechts, Diether; van Gorp, Toon Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A340 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2022-RA-884-ESGO Whole-body diffusion-weighted MRI (WB-DWI/MRI) for the prediction of resectable disease at the time of secondary cytoreductive surgery for relapsed epithelial ovarian cancer. (20th October 2022) Authors: Dumont, Sander; Vandecaveye, Vincent; Dresen, Raphaëla Carmen; van Nieuwenhuysen, Els; Baert, Thaïs; Han, Sileny; Neven, Patrick; Berteloot, Patrick; Amant, Frédéric; van Gorp, Toon Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A273 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A new era of improving progression-free survival with dual blockade in postmenopausal HR+, HER2− advanced breast cancer. Issue 2 (February 2015) Authors: Jerusalem, Guy; Bachelot, Thomas; Barrios, Carlos; Neven, Patrick; Di Leo, Angelo; Janni, Wolfgang; de Boer, Richard Journal: Cancer treatment reviews Issue: Volume 41:Issue 2(2015) Page Start: 94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A Systematic Review of Estimating Breast Cancer Recurrence at the Population Level With Administrative Data. (7th April 2020) Authors: Izci, Hava; Tambuyzer, Tim; Tuand, Krizia; Depoorter, Victoria; Laenen, Annouschka; Wildiers, Hans; Vergote, Ignace; Van Eycken, Liesbet; De Schutter, Harlinde; Verdoodt, Freija; Neven, Patrick Journal: Journal of the National Cancer Institute Issue: Volume 112:Number 10(2020) Page Start: 979 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial. Issue 1 (January 2023) Authors: Johnston, Stephen R D; Toi, Masakazu; O'Shaughnessy, Joyce; Rastogi, Priya; Campone, Mario; Neven, Patrick; Huang, Chiun-Sheng; Huober, Jens; Jaliffe, Georgina Garnica; Cicin, Irfan; Tolaney, Sara M; Goetz, Matthew P; Rugo, Hope S; Senkus, Elzbieta; Testa, Laura; Del Mastro, Lucia; Shimizu, Chika... Journal: Lancet oncology Issue: Volume 24:Issue 1(2023) Page Start: 77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Advances in the treatment of advanced oestrogen-receptor-positive breast cancer. Issue 10087 (17th June 2017) Authors: Turner, Nicholas C; Neven, Patrick; Loibl, Sibylle; Andre, Fabrice Journal: Lancet Issue: Volume 389:Issue 10087(2017) Page Start: 2403 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Age‐dependent brain volume and neuropsychological changes after chemotherapy in breast cancer patients. Issue 17 (21st August 2019) Authors: Blommaert, Jeroen; Schroyen, Gwen; Vandenbulcke, Mathieu; Radwan, Ahmed; Smeets, Ann; Peeters, Ron; Sleurs, Charlotte; Neven, Patrick; Wildiers, Hans; Amant, Frédéric; Sunaert, Stefan; Deprez, Sabine Journal: Human brain mapping Issue: Volume 40:Issue 17(2019) Page Start: 4994 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Age‐related remodelling of the blood immunological portrait and the local tumor immune response in patients with luminal breast cancer. Issue 10 (3rd October 2020) Authors: Berben, Lieze; Floris, Giuseppe; Kenis, Cindy; Dalmasso, Bruna; Smeets, Ann; Vos, Hanne; Neven, Patrick; Antoranz Martinez, Asier; Laenen, Annouschka; Wildiers, Hans; Hatse, Sigrid Journal: Clinical & translational immunology Issue: Volume 9:Issue 10(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study. Issue 4 (April 2021) Authors: Rugo, Hope S; Lerebours, Florence; Ciruelos, Eva; Drullinsky, Pamela; Ruiz-Borrego, Manuel; Neven, Patrick; Park, Yeon Hee; Prat, Aleix; Bachelot, Thomas; Juric, Dejan; Turner, Nicholas; Sophos, Nickolas; Zarate, Juan Pablo; Arce, Christina; Shen, Yu-Ming; Turner, Stuart; Kanakamedala, Hemanth; H... Journal: Lancet oncology Issue: Volume 22:Issue 4(2021) Page Start: 489 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗